文献速递生殖医学

孕酮给药6天或7天后行冻融囊胚移植:对激素替代治疗周期活产率的影响

Frozen-warmed blastocyst transfer after 6 or 7 days of progesterone administration: impact on live birth rate in hormone replacement therapy cycles.
PubMed 文献 · Fertil Steril · 2020-06-16

回顾性队列研究纳入2015年12月至2017年12月激素替代治疗周期冻融囊胚移植患者619例,比较孕酮给药第6天(A组346例)与第7天(B组273例)移植的活产率。两组活产率均为36.6%,校正后比值比1.073(95%CI 0.740-1.556)。亚组分析显示第6天囊胚在孕酮第6天移植的流产率显著高于第7天移植(50.0% vs 21.4%)。

要点

  • 激素替代周期孕酮给药第6天与第7天行冻融囊胚移植的活产率相似(均为36.6%)。
  • 第6天囊胚在孕酮第6天移植的流产率显著高于孕酮第7天移植(50.0% vs 21.4%)。
  • 第6天囊胚采用7天孕酮方案移植时活产率有升高趋势(A组21.5% vs B组35.5%)。

核心结论

  • 激素替代周期中孕酮给药第6天与第7天行冻融囊胚移植的活产率相似。
  • 第6天囊胚亚组分析显示孕酮第6天移植的流产率显著高于第7天移植。

研究设计与样本

  • 回顾性队列研究,纳入2015年12月至2017年12月在三级大学附属转诊医院行激素替代治疗周期冻融囊胚移植的患者619例(A组346例,B组273例)。
  • A组为孕酮给药第6天行冻融囊胚移植,B组为孕酮给药第7天移植。
  • 激素替代方案为雌激素2 mg每日两次用7天后改为2 mg每日三次用6天,内膜厚度合适后开始微粒化阴道孕酮200 mg每日三次。

主要发现

  • 两组活产率均为36.6%,校正混杂因素后比值比1.073(95%CI 0.740-1.556)。
  • 第6天囊胚亚组中,孕酮第6天移植的流产率为50.0%,孕酮第7天移植为21.4%。
  • 第6天囊胚亚组中,孕酮第7天方案移植的活产率有升高趋势(A组21.5% vs B组35.5%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the difference in live birth rate (LBR) between frozen-warmed blastocyst transfer (FET) on the 6th or the 7th day of progesterone administration in artificially prepared cycles. DESIGN: Retrospective cohort study. SETTING: Tertiary university-based referral hospital. PATIENT(S): Patients who underwent FET between December 2015 and December 2017 in a hormone replacement therapy cycle (HRT). INTERVENTION(S): Group A included all eligible patients who underwent transfer of a vitrified-warmed blastocyst on the 6th day of progesterone administration; group B included patients who underwent blastocyst transfer on the 7th day of progesterone. The artificial HRT protocol in this study consisted of estrogen administration at a dose of 2 mg twice daily for 7 days followed by 2 mg three times daily for 6 days and micronized vaginal progesterone 200 mg three times daily from an adequately considered endometrial thickness onward. MAIN OUTCOME MEASURE(S): Live birth rate. RESULTS: The study included 619 patients, 346 in group A and 273 in group B. The LBRs were comparable between both groups (36.6% for group A and group B), even after adjustment for confounding factors (adjusted odds ratio 1.073, 95% confidence interval 0.740-1.556). Subgroup analysis revealed significantly higher miscarriage rates for day 6 blastocysts transferred on the 6th day of progesterone supplementation compared with transfer on the 7th day of progesterone supplementation (50.0% versus 21.4%, respectively). Additionally, there was a tendency toward a higher LBR when the 7-day progesterone supplementation protocol was used for transfer of a day 6 blastocyst (21.5% and 35.5% for group A and group B, respectively). CONCLUSION: Warmed blastocyst transfer on the 6th compared with the 7th day of progesterone administration in an HRT cycle results in similar LBR. Subgroup analysis of day 6 blastocysts showed significantly higher miscarriage rates when FET was performed on the 6th day of progesterone administration.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Roelens C, Santos-Ribeiro S, Becu L, et al. Frozen-warmed blastocyst transfer after 6 or 7 days of progesterone administration: impact on live birth rate in hormone replacement therapy cycles. Fertil Steril. 2020. PMID: 32553469. doi:10.1016/j.fertnstert.2020.03.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。